Enalapril Related Published Studies
Well-designed clinical trials related to Enalapril
Efficacy of folic acid and enalapril combined therapy on reduction of blood pressure and plasma glucose: A multicenter, randomized, double-blind, parallel-controlled, clinical trial. [2008.11]
Blood pressure-lowering efficacy of amiloride versus enalapril as add-on drugs in patients with uncontrolled blood pressure receiving hydrochlorothiazide. [2008.10]
Long-term effect of a chicken-based diet versus enalapril on albuminuria in type 2 diabetic patients with microalbuminuria. [2008.09]
Efficacy of folic acid and enalapril combined therapy on reduction of blood pressure and plasma glucose: A multicenter, randomized, double-blind, parallel-controlled, clinical trial. [2008.07.23]
Combination therapy with amiodarone and enalapril in patients with paroxysmal atrial fibrillation prevents the development of structural atrial remodeling. [2008.07]
Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency. [2007.10.01]
An evaluation of the initial and long-term antihypertensive efficacy of zofenopril compared with enalapril in mild to moderate hypertension. [2007.10]
The effect of amlodipine and the combination of amlodipine and enalapril on the renin-angiotensin-aldosterone system in the dog. [2007.10]
Effects of intracoronary low-dose enalaprilat on ventricular repolarization dynamics after direct percutaneous intervention for acute myocardial infarction. [2007.05]
Pretreatment with intracoronary enalaprilat protects human myocardium during percutaneous coronary angioplasty. [2007.04.17]
Enalapril/amlodipine combination in cyclosporine-treated renal transplant recipients: a prospective randomized trial. [2007.03]
Intracoronary enalaprilat during angioplasty for acute myocardial infarction: alleviation of postischaemic neurohumoral and inflammatory stress? [2007.02]
Treatments with losartan or enalapril are equally sensitive to deterioration in renal function from cyclooxygenase inhibition. [2007.02]
Efficacy of indapamide SR compared with enalapril in elderly hypertensive patients with type 2 diabetes. [2007.01]
Low doses of intracoronary enalaprilat suppress reperfusion-associated ventricular arrhythmias after primary percutaneous coronary interventions for acute myocardial infarction. [2007.01]
Efficacy and tolerability of trandolapril in mild to moderate hypertension--a double blind comparative clinical trial with enalapril in Indian population. [2006.10]
Dual blockade of angiotensin II with enalapril and losartan reduces proteinuria in hypertensive patients with type 2 diabetes. [2006.08]
Influence of nebivolol and enalapril on metabolic parameters and arterial stiffness in hypertensive type 2 diabetic patients. [2006.07]
Comparison of the dual receptor endothelin antagonist enrasentan with enalapril in asymptomatic left ventricular systolic dysfunction: a cardiovascular magnetic resonance study. [2006.06]
Comparative effects of valsartan and enalapril on cardiac sympathetic nerve activity and plasma brain natriuretic peptide in patients with congestive heart failure. [2006.05]
Preventing renal complications in type 2 diabetes: results of the diabetics exposed to telmisartan and enalapril trial. [2006.04]
Prevalence and prognostic significance of anemia in patients with congestive heart failure treated with standard vs high doses of enalapril. [2006.03]
[Head-to-head comparison of clinical, biochemical and functional effects of fosinopril and enalapril in patients with systolic heart failure] [2006.01]
Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension. [2006.01]
Efficacy and safety of 24 weeks of therapy with bendroflumethiazide 1.25 mg/day or 2.5 mg/day and potassium chloride compared with enalapril 10 mg/day and amlodipine 5 mg/day in patients with mild to moderate primary hypertension : a multicentre, randomised, open study. [2006]
Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study. [2005.11]
Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III. [2005.10.18]
Enalapril suppresses ventricular remodeling more effectively than losartan in patients with acute myocardial infarction. [2005.10]
Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both. [2005.09.01]
Neurohormonal and circulatory effects of short-term treatment with enalapril and quinapril in dogs with asymptomatic mitral regurgitation. [2005.09]
[Double blind study of the efficacy and safety of the fixed dose combination of enalapril 10 mg/nitrendipine 20 mg versus the increase of amlopidine dose in essential hypertensive patients not controlled with amlodipine 5 mg] [2005.09]
Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic study. [2005.08]
Comparison of the effect of enalapril and losartan in conjunction with surgical coronary revascularisation versus revascularisation alone on systemic endothelial function. [2005.08]
Effects of perindopril on cardiac sympathetic nerve activity in patients with congestive heart failure: comparison with enalapril. [2005.08]
Incidence and characteristics of angioedema associated with enalapril. [2005.07.25]
Effect of enalapril on left ventricular diameters and exercise capacity in asymptomatic or mildly symptomatic patients with regurgitation secondary to mitral valve prolapse or rheumatic heart disease. [2005.07.01]
Effects of nifedipine GITS 20 mg or enalapril 20 mg on blood pressure and inflammatory markers in patients with mild-moderate hypertension. [2005.07]
Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis. [2005.04]
Enalapril dosage in progressive chronic nephropathy: a randomised, controlled trial. [2005.04]
Effect of treatment with candesartan or enalapril on subcutaneous small artery structure in hypertensive patients with noninsulin-dependent diabetes mellitus. [2005.04]
Stabilization and regression of albuminuria in Chinese patients with type 2 diabetes: a one-year randomized study of valsartan versus enalapril. [2005.03]
[Hypotensive effectiveness of therapy combined enalapril and nitrendipine and influence on the quality of life] [2005.03]
Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study. [2005.02]
Effects of candesartan cilexetil and enalapril on inflammatory markers of atherosclerosis in hypertensive patients with non-insulin-dependent diabetes mellitus. [2005.02]
Enalapril influence on blood pressure and echocardiographic parameters in children with acute postinfectious glomerulonephritis. [2005]
Well-designed clinical trials possibly related to Enalapril
17Beta-estradiol increases basal but not bradykinin-stimulated release of active t-PA in young postmenopausal women. [2008.04]
Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment. [2008.03]
Renal response to angiotensin II is blunted in sodium-sensitive normotensive men. [2008.03]
Impact of the preintervention rate of renal function decline on outcome of renoprotective intervention. [2008.01]
Inflammatory activation during coronary artery surgery and its dose-dependent modulation by statin/ACE-inhibitor combination. [2007.12]
Comparison of high- versus low-tissue affinity ACE-inhibitor treatment on circulating aldosterone levels in patients with chronic heart failure. [2007.12]
Haemodynamic and renal effects of endothelin receptor antagonism in patients with chronic kidney disease. [2007.11]
Mitral insufficiency and morbidity and mortality in left ventricular dysfunction. [2007.08]
Impact of neurohormonal blockade on association between body mass index and mortality. [2007.06.25]
Dechallenge and rechallenge method showed different incidences of cough among four ACE-Is. [2007.06]
A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy. [2007.04]
Revival of nifedipine, a dihydropyridine-based calcium blocker. [2007]
Indapamide decreases plasma adiponectin concentration in patients with essential hypertension. [2007]
Bisoprolol in the treatment of chronic heart failure. [2007]
Ambulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapy. [2007]
Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition. [2006.12.05]
The relation of ambulatory blood pressure and pulse rate to retinopathy in type 1 diabetes mellitus: the renin-angiotensin system study. [2006.12]
Effect of angiotensin converting enzyme inhibitors on 1.25-(OH)2 D levels of hypertensive patients. Relationship with ACE polymorphisms. [2006.12]
The influence of cardiovascular and antiinflammatory drugs on thiazide-induced hemodynamic and saluretic effects. [2006.11]
Effects of monotherapy and combination therapy on blood pressure control and target organ damage: a randomized prospective intervention study in a large population of hypertensive patients. [2006.09]
Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes. [2006.09]
Correlation of flow mediated dilation with inflammatory markers in patients with impaired cardiac function. Beneficial effects of inhibition of ACE. [2006.08]
Angiotensin-converting enzyme inhibitors slow recovery from anemia following cardiac surgery. [2006.07]
Effects of ACE Inhibition and Angiotensin II Receptor Blockade on Glomerular Basement Membrane Protein Excretion and Charge Selectivity in Type 2 Diabetic Patients. [2006.06]
A review of isosorbide dinitrate and hydralazine in the management of heart failure in black patients, with a focus on a new fixed-dose combination. [2006.05]
The effect of sodium and angiotensin-converting enzyme inhibition on the classic circulating renin-angiotensin system in autosomal-dominant polycystic kidney disease patients. [2006.05]
Clinical trial to evaluate omega-3 fatty acids and alternate day prednisone in patients with IgA nephropathy: report from the Southwest Pediatric Nephrology Study Group. [2006.05]
ETa-receptor blockade, but not ACE inhibition, blunts retinal vessel response during isometric exercise. [2006.04]
Changes in aortic stiffness and augmentation index after acute converting enzyme or vasopeptidase inhibition. [2005.11]
Impact of the angiotensin II receptor antagonist, losartan, on myocardial fibrosis in patients with end-stage renal disease: assessment by ultrasonic integrated backscatter and biochemical markers. [2005.10]
Cyclooxygenase inhibition causes marked impairment of renal function in elderly subjects treated with diuretics and ACE-inhibitors. [2005.10]
Felodipine-metoprolol combination tablet: maintained health-related quality of life in the presence of substantial blood pressure reduction. [2005.10]
Long-term vasodilator therapy in patients with severe aortic regurgitation. [2005.09.29]
Enhancement of blood glucose lowering effect of a sulfonylurea when coadministered with an ACE inhibitor: results of a glucose-clamp study. [2005.09]
Effects of angiotensin-converting enzyme inhibitor plus irbesartan on maximal and submaximal exercise capacity and neurohumoral activation in patients with congestive heart failure. [2005.05]
Design and baseline characteristics of participants in the study of antihypertensive therapy in children and adolescents with autosomal dominant polycystic kidney disease (ADPKD). [2005.04]
B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure. [2005.04]
Effect of fixed-dose ACE-inhibitor/calcium channel blocker combination therapy vs. ACE-inhibitor monotherapy on arterial compliance in hypertensive patients with type 2 diabetes. [2005.03]
The effect of gender on outcome in digitalis-treated heart failure patients. [2005.03]
The effect of an angiotensin-converting enzyme inhibitor and a K+(ATP) channel opener on warm up angina. [2005.03]
[Changes of serum asymmetric dimethylarginine in essential hypertension before and after the treatment] [2005.02]
Other research related to Enalapril
Efficacy of exercise, losartan, enalapril, atenolol and rilmenidine in subjects with blood pressure hyperreactivity at treadmill stress test and left ventricular hypertrophy. [2008.10.23]
Ranolazine Combined with Enalapril or Metoprolol Prevents Progressive LV Dysfunction and Remodeling in Dogs with Moderate Heart Failure. [2008.09.26]
The effect of enalapril and telmisartan on clinical and biochemical indices of sympathetic activity in hypertensive patients. [2008.07]
[Interventions of enalapril on airway inflammation in rat models induced by acrolein] [2008.07]
Clinical Effects of Initial 6 Months Monotherapy with Bisoprolol versus Enalapril in the Treatment of Patients with Mild to Moderate Chronic Heart Failure. Data from the CIBIS III Trial. [2008.06.05]
Transdermal therapeutic system of enalapril maleate using piperidine as penetration enhancer. [2008.04]
Fixed-dose lercanidipine/enalapril for hypertension. [2008.04]
Both enalapril and losartan attenuate sarcolemmal Na+-K+-ATPase remodeling in failing rat heart due to myocardial infarction. [2008.04]
The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study. [2008.03]
Prevention of DNA damage in renal transplantation by losartan and enalapril: the role of renin-angiotensin system polymorphisms. [2008.02]
Enalaprilat induced acute parotitis. [2008.02]
Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: A prospective, randomized, open-label, blinded end-point trial. [2008.01]
Effects of losartan and enalapril on high-sensitivity C-reactive protein and total antioxidant in renal transplant recipients with Renin-Angiotensin system polymorphisms. [2008.01]
[Efficacy and safety of Enalapril-Folate acid tablets in lowering blood pressure and plasma homocysteine.] [2007.12.18]
Lercanidipine, enalapril and their combination in the treatment of elderly hypertensive patients: placebo-controlled, randomized, crossover study with four ABPM. [2007.12]
|
